Company Filing History:
Years Active: 2019
Title: Alex Salyer: Innovator in HPV Immunotherapy
Introduction
Alex Salyer is a notable inventor based in Houston, Texas. He has made significant contributions to the field of immunotherapy, particularly in the context of human papillomavirus (HPV) infections and related diseases. His work focuses on the generation of HPV-specific T-cells, which are crucial for developing effective treatments.
Latest Patents
Salyer holds a patent for the "Generation of HPV-specific T-cells." This patent encompasses methods and compositions aimed at immunotherapy for HPV infections. The specific embodiments of his patent detail the production of immune cells that target antigens of HPV16 and/or HPV18. Notably, his methods include stimulation steps that utilize IL-7 and IL-15, while avoiding IL-6 and/or IL-12. Additionally, certain embodiments involve stimulations in the presence of costimulatory cells and specific antigen-presenting cells.
Career Highlights
Alex Salyer is affiliated with the Baylor College of Medicine, where he continues to advance research in immunotherapy. His work has the potential to significantly impact the treatment of HPV-related diseases, contributing to the broader field of cancer immunology.
Collaborations
Salyer collaborates with esteemed colleagues, including Carlos A. Ramos and Cliona M. Rooney. These partnerships enhance the research efforts and foster innovation in the development of new therapeutic strategies.
Conclusion
Alex Salyer's contributions to HPV immunotherapy through his innovative patent and collaborative efforts mark him as a significant figure in the field. His work holds promise for improving treatment options for HPV-related conditions.